FDA DEVICE FACTS
Dexcom G6 Continuous Glucose Monitoring (CGM) System
Dexcom, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons age 2 years and older. The Dexcom G6 System is intended to replace fingerstick blood glucose testing for diabetes treatment decisions. Interpretation of the Dexcom G6 System results should be based on the glucose trends and several sequential readings over time. The Dexcom G6 System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. The Dexcom G6 System is also intended to autonomously communicate with digitally connected devices, including automated insulin dosing (AID) systems. The Dexcom G6 System can be used alone or in conjunction with these digitally connected medical devices for the purpose of mana ging diabetes. Same Clinical Application Management of diabetes mellitus Same Clinical Setting/Sites of Use Home Use Same Principle of Operation Amperometric measurement of current proportional to glucose concentration in interstitial fluid via glucose oxidase chemical reaction. Same Data Presented Estimated Glucose Value (EGV): The EGV is the nominal glucose value presented to the user. Glucose Trend: Based off the glucose rate of change, users are shown their glucose trend with a corresponding arrow. Historical Glucose Data: Users can view their previous three, six, twelve, or twent y-four hours of glucose data. Same Glucose Value Estimation Algorithm Joint Probability Algorithm Same Factory Calibration Yes Same Optional Calibration Yes Same Features Connect to Dexcom Share: Users can share their glucose data with followers. Partner Web APIs: Users can share their glucose data with client software. Same Human Factors System usability validated through human factors testing. Same Compatibility with Intended Environments Android OS and Apple iOS Same Receiver Touchscreen Receiver Non-touchscreen receiver.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。